Persbericht Biocartis Group NV: SeptiCyte® RAPID krijgt 510(k) clearance van de US FDA
November 30, 2021 11:40 ET
|
Biocartis NV
PERSBERICHT: 30 november 2021, 17:40 CET SeptiCyte® RAPID krijgt 510(k) clearance van de US FDA Mechelen, België, 30 november 2021 – Biocartis Group NV (de ‘Vennootschap’ of ‘Biocartis’), een...
Press release Biocartis Group NV: SeptiCyte® RAPID Receives 510(k) clearance by US FDA
November 30, 2021 11:40 ET
|
Biocartis NV
PRESS RELEASE: 30 November 2021, 17:40 CET SeptiCyte® RAPID Receives 510(k) clearance by US FDA Mechelen, Belgium, 30 November 2021 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an...